{"name":"MinaPharm Pharmaceuticals","slug":"minapharm-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"UDCA 250mg","genericName":"UDCA 250mg","slug":"udca-250mg","indication":"Other","status":"marketed"},{"name":"Ciprodiazole","genericName":"Ciprodiazole","slug":"ciprodiazole","indication":"Other","status":"marketed"},{"name":"Ursoplus","genericName":"Ursoplus","slug":"ursoplus","indication":"Other","status":"marketed"},{"name":"Xerovirinc in Arm 2","genericName":"Xerovirinc in Arm 2","slug":"xerovirinc-in-arm-2","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Reiferon Retard in Arm 1","genericName":"Reiferon Retard in Arm 1","slug":"reiferon-retard-in-arm-1","indication":"Chronic hepatitis C","status":"marketed"},{"name":"Reiferon retard","genericName":"Reiferon retard","slug":"reiferon-retard","indication":"Chronic hepatitis C","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"r-Hirudin","genericName":"r-Hirudin","slug":"r-hirudin","indication":"Acute coronary syndrome","status":"marketed"},{"name":"Bon one in Arm 3","genericName":"Bon one in Arm 3","slug":"bon-one-in-arm-3","indication":"Atrial fibrillation for stroke prevention","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Ciprofloxacin Tablets & Metronidazole tablets","genericName":"Ciprofloxacin Tablets & Metronidazole tablets","slug":"ciprofloxacin-tablets-metronidazole-tablets","indication":"Bacterial infections caused by susceptible aerobic and anaerobic organisms","status":"marketed"},{"name":"Ribavirin in Arm 1","genericName":"Ribavirin in Arm 1","slug":"ribavirin-in-arm-1","indication":"Chronic hepatitis C (in combination with interferon or direct-acting antivirals)","status":"marketed"}]}],"pipeline":[{"name":"Reiferon Retard in Arm 1","genericName":"Reiferon Retard in Arm 1","slug":"reiferon-retard-in-arm-1","phase":"marketed","mechanism":"Reiferon Retard is a long-acting interferon alfa-2a that activates innate and adaptive immune responses to inhibit viral replication and tumor cell growth.","indications":["Chronic hepatitis C","Chronic hepatitis B","Certain hematologic malignancies (e.g., chronic myeloid leukemia, lymphomas)"],"catalyst":""},{"name":"r-Hirudin","genericName":"r-Hirudin","slug":"r-hirudin","phase":"marketed","mechanism":"r-Hirudin is a recombinant direct thrombin inhibitor that prevents blood clot formation by blocking thrombin's ability to convert fibrinogen to fibrin.","indications":["Acute coronary syndrome","Thromboembolism prevention"],"catalyst":""},{"name":"UDCA 250mg","genericName":"UDCA 250mg","slug":"udca-250mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bon one in Arm 3","genericName":"Bon one in Arm 3","slug":"bon-one-in-arm-3","phase":"marketed","mechanism":"Bon one in Arm 3 is a medication that works by [insert mechanism here, if known]","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Ciprodiazole","genericName":"Ciprodiazole","slug":"ciprodiazole","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ciprofloxacin Tablets & Metronidazole tablets","genericName":"Ciprofloxacin Tablets & Metronidazole tablets","slug":"ciprofloxacin-tablets-metronidazole-tablets","phase":"marketed","mechanism":"This combination product uses ciprofloxacin to inhibit bacterial DNA gyrase and topoisomerase IV, while metronidazole generates reactive intermediates that damage DNA in anaerobic microorganisms.","indications":["Bacterial infections caused by susceptible aerobic and anaerobic organisms","Mixed aerobic-anaerobic infections","Intra-abdominal infections","Gynecological infections"],"catalyst":""},{"name":"Reiferon retard","genericName":"Reiferon retard","slug":"reiferon-retard","phase":"marketed","mechanism":"Reiferon retard is a long-acting formulation of interferon alfa-2a that activates innate and adaptive immune responses to inhibit viral replication and tumor cell growth.","indications":["Chronic hepatitis C","Chronic hepatitis B","Certain hematologic malignancies (e.g., chronic myeloid leukemia, lymphomas)"],"catalyst":""},{"name":"Ribavirin in Arm 1","genericName":"Ribavirin in Arm 1","slug":"ribavirin-in-arm-1","phase":"marketed","mechanism":"Ribavirin is a nucleoside analog that inhibits viral RNA synthesis by interfering with the viral polymerase and depleting guanosine nucleotide pools.","indications":["Chronic hepatitis C (in combination with interferon or direct-acting antivirals)","Severe respiratory syncytial virus (RSV) infection","Hemorrhagic fever with renal syndrome","Lassa fever"],"catalyst":""},{"name":"Ursoplus","genericName":"Ursoplus","slug":"ursoplus","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Xerovirinc in Arm 2","genericName":"Xerovirinc in Arm 2","slug":"xerovirinc-in-arm-2","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQZng1YnRLZ3ctelZTc2lpV1h4cG1tenhBaHpGVTduNTFRNDVwdXR6VzVjSjRpYzlkMk9CNDAxZEI0ZnQwSFdKNHFQekVtbDZtZmNQczJPUTgyZWFuQ0F5SHRMUkcyQU5EQU1LTXVldlRnb1oxT2tNa3hGTU1BTG4xV3dzb2hNMjVDM0R6NW5CUW50amo5dm4wMzV5OHBPa2F1UW0xY2VDbkNhTm41M21peUtXM3B2QUQ1WHdUbFdR?oc=5","date":"2026-01-27","type":"deal","source":"africabusinessplus.com","summary":"Adenia acquires Parkville Pharmaceuticals in landmark deal as Admaius exits - africabusinessplus.com","headline":"Adenia acquires Parkville Pharmaceuticals in landmark deal as Admaius exits","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOWjZyd0RaZjBheVRNRENZeDVIMHNhbUNfcDVVcVNNaUJtcFdubWEwemUtS0ctLTdld2NteThBNDNEQzBxS2VWTEFMdmNSWkJfSm1jYy1BNFJ0b1ZZZ2cxZ21VX0J2M0loZncyR0FMRHZaZmRlVUluanpjYUFqaXRxUW9tQzZhd2RJOXRYcTdyNEtHNGVodk92bkFSS0w?oc=5","date":"2026-01-22","type":"pipeline","source":"آراب فاينانس","summary":"Minapharm Pharmaceuticals in talks over €13.25M EBRD loan - آراب فاينانس","headline":"Minapharm Pharmaceuticals in talks over €13.25M EBRD loan - آراب فاينانس","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQVN2NV92TWpaY19xc3BCWjdqU2Q0Q0xtM1RXZDY4cFNhWWM4R3hsLUVXd0RibFZ1MzZBNEdzMWFrRjB1Y0FTaUdBdXFWOWE3cml4U0J4R2FOQ2ZxRWVWOFMwU21Lb3pUNEZfWHAtNDF1Z1BiMTIzNlA4b0FXaE1OekRRMC1Gc2FDSkJlUGYwdkZJSlY3M2FuWVJFQS1GOUo0TmZ4UlREQkJNQjB4MGF1QnpEUVkyQXJCTjAtYU9ZOEFHZw?oc=5","date":"2025-12-09","type":"deal","source":"AUC","summary":"AUC Supports the Establishment of Africa's First Biotech Academy Through New Minapharm Collaboration - AUC","headline":"AUC Supports the Establishment of Africa's First Biotech Academy Through New Minapharm Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYm53MGFJWEVKNDhpVmJnMUtMdno3eHk0RFdpNHl0YkpuWGhsbFV1bDhmQkZ3TkRobnAxTnZJT0pvUHdPVG52d1kzVHIyWUU3VDBORXV3SXVxQ2VOU2xxbHpTdWhtSDJaSUUyb3pfRVd4cVZPamhVOUZZLS0wT1FVczdMRlN1NzYzRVBReEx3N3JuVTRQVV9QSDlndlRkcEFGcXotYWMzLWYtUQ?oc=5","date":"2025-11-15","type":"deal","source":"الهيئة العامة للاستعلامات","summary":"'Minapharm' inks strategic coop. deal with German pharma giant 'Bayer' - الهيئة العامة للاستعلامات","headline":"'Minapharm' inks strategic coop. deal with German pharma giant 'Bayer' - الهيئة العامة للاستعلامات","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE96aGdySklxcUxZVXRwbFBxcWdGb0l6UjN3b3MyRC1Ld2RxaEsyenhVSDFMUmdKOFNYTmFjd0tkeDJWTXdEazhYcDRSSUFXOTk1LU5BWHBuSVQ?oc=5","date":"2025-11-15","type":"pipeline","source":"Ahram Online","summary":"Minapharm and Bayer Announce a Strategic Cooperation to Localize Pharmaceutical Manufacturing and Strengthen Egypt as the ‘Gateway to Africa’ - Sponsored - Advertising - Ahram Online","headline":"Minapharm and Bayer Announce a Strategic Cooperation to Localize Pharmaceutical Manufacturing and Strengthen Egypt as th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxPSm9sTlQtMHpoZ0FqUUpsSHlEZGlYYlgzTU9QWEVoLUdHU0FMd2dYNjhIY3JtYXdVQ0M1RzhMZUg2MDVZam9hOW1IWGNQY3hybnNhNUIzbzZlazVOWjFhdVNCQ2tTTE01VFlDeEltS2NnZUVLV3YxekJlWHpCVUhZRG5fM2Z6QTE0dVBsUXFIc29ZMjgwMVlydlZ2S3U5Qy1obVN3OE5wUE9pRmVFTHkxOExXd3U0SHlQY1VTcnpnTmpSRUhsQWxhZ3JtTGl3ODBOZWNUV0xLSFI0OWtwMFQ5cHJlYTl0WVlVcnc4V3BNNzZzenlQaklWS0NhRFlFekVVNllKeG56alNiX2FZTy02eWJMTUdKa1VodTBFM21IaUFoZVVMQWF6SDg0T0Y2UHRfUkdBZU53LWZYZTVQRUtRd2hJbnRtZw?oc=5","date":"2025-11-15","type":"pipeline","source":"هيئة الدواء المصرية","summary":"Egyptian Drug Authority Witnesses the Signing of a Cooperation Agreement between “Minapharm” and “Bayer” to Localize Pharmaceutical Industry and Boost Pharmaceutical Investments - هيئة الدواء المصرية","headline":"Egyptian Drug Authority Witnesses the Signing of a Cooperation Agreement between “Minapharm” and “Bayer” to Localize Pha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxQbjNGQjc3ZUV4Z3Nyd3BhdW5GdHk3TUdWeWhVWXp1WTZyOW9QSDF3bVBpRG1HaWF2OXkySk5FUnU4dXFzWkptUGp1cnRwRUtWYld0VjJfZmh3S3hvdlZEZXJtRzRpelZManBzdWp2bEhLTkw5MlljQnM0N3cxV1pLcy1CY3hQcFUxTFktTWJtNHdSSTcxeV9LaGdGZmtWSW5jRGJlLUZwMFRIWjJIOUpvSk9MUzJ0VGI2REJmLVp6NkljR05PSVV6c1RLVVBhbS0wQnhFVXVFU1ZnWWFjXzZyMDlBS0VZZm5nbDdCM3VPenE3M1BPQmplZXctVXdORWZ0LUVWd09nTkdYYjVEMmFsTTJzREZ6X3NSYWNpckZLMU52eW11WE9iN3ZfZS1xQTdEcDB0UVIzSnBJdw?oc=5","date":"2025-10-10","type":"pipeline","source":"IAVI","summary":"IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa - IAVI","headline":"IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOYWlUdjg2OU1QMmxhQ3oxNVhnODE3TWFSRXBsS0J2cFdTanRweTduUXAyQ1gtV3lIdXZTMU1uQ0pucXA5eWFFOHJVUHZubVpIM21LSktjMHpCUmc0MUhQTXg0bk9Makg4M3N0RkhVSDdxMnRzMG1LdWUtaGdkQlVWcXh0cFdNN3JPMENsakVpd1k0SUFOZmdqYTlZbHlpbFN2YjVzQlNQbS1PTWhoOFIwSnRsa0xGcFczakRtOWZKQVFDRnpBbUVMZF91TQ?oc=5","date":"2025-10-10","type":"deal","source":"Contract Pharma","summary":"IAVI, Minapharm, & ProBioGen Launch Vaccine & Biologics Manufacturing Partnership in Africa - Contract Pharma","headline":"IAVI, Minapharm, & ProBioGen Launch Vaccine & Biologics Manufacturing Partnership in Africa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTFRlQWZnRGtuWVRnUTh1NFBVOFUtWGduNXR1NlNhcUp5Mkw0U1Mtdjg2RE5ITmlUTm9LdGNRdkptOElsODgyM0p3b1QwTER6UG1jSjktMHNkSVJmaThxRlMxMlhxUnlYUTljZnNRMEVYcEV3M0NGWFpJck9xenFYeXZORmhhcDM0V1RzZ3YwZ3h1d2hyRVRUV1BRcWthZXRjV29iMUNKanBHRTdIUmRtYUZaU0xXZVc4R3Z3ZWZSMUxsTVBhYmd5X2luM2xwZnJaU3ZnbnRZRFlKT3pIb3BBa3lDMk05bF8xeEE?oc=5","date":"2025-07-28","type":"deal","source":"investorsinhealthcare.com","summary":"Egypt: Minapharm majority shareholder Triquera gains investment from Admaius Capital Partners - investorsinhealthcare.com","headline":"Egypt: Minapharm majority shareholder Triquera gains investment from Admaius Capital Partners","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQT3k1MVhxMUhYa2VPdU1nNEZJeEJ3YmNrVFB0ajBfZDQwbEEyVkJjZTFTSE0tS2lyU1haQzJBQWJkOHMtX2NOOXJiZDJUd0hzYTV0R1NfMjc5bjdxN0wxNTlYUW03S3BrXzhrVFp2RzA3TjYxSzBhUHFwZDRza2wzNXo1WUluYTFXRGdNdkk4bkNhRGNfVE1tWTZsUG1wV3hYTXpoc3JyX1ZyRVlKNnZXVkRaNFFYd0Y5RWo5VHk3MTFHc1lG?oc=5","date":"2025-05-25","type":"pipeline","source":"dailynewsegypt.com","summary":"AfDB commits $746M to Egypt in 2025, targeting private sector, pharma, and clean energy - dailynewsegypt.com","headline":"AfDB commits $746M to Egypt in 2025, targeting private sector, pharma, and clean energy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQSjE3eXdVWUNndFI5WktzWTVQVFVFV2FCUjZRcTFiMnVnVWRPSWdZSkF0WGpQN053cElQdzFMaS16UVc0R2JuRGJrTlF1bkhMelpOOE15dUdfOUxDWjdWZG5XVjBZdjNtM1Q1Z0tFOXFPUkhYUVFnTGk1QXJBWGloLTV6REFWalRuQWJvaWZDUkNmZGtwTElIS0FNN3FlSlJXdjM3YlFHVEV3WUpIbjJxYm5Ob2I1THQzbWZFMnlEMjU1R1ExTWZkMGk0bHBVaE5uVWxKTjNkSlFxWG1pNTFEYzM0SkNJOVMxZ3BNQ09OWEptMTNyVG5iRA?oc=5","date":"2025-03-26","type":"regulatory","source":"African Development Bank Group","summary":"African Development Bank approves EUR 15 Million loan to boost Biosimilars’ Development and Production in Egypt - African Development Bank Group","headline":"African Development Bank approves EUR 15 Million loan to boost Biosimilars’ Development and Production in Egypt","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMldkTjJHY1M5aWdZRV85SEpJczZjZEg1QjcyN3A4dkNiSEpGUFFpRXR6MlRmSy1pSWpjTGlvMHRpSjQwUG00UG4zeVRIajZWZjQxS28tazVzcEQzWGZRT1I1dmRDWTctRzlELWkzcHJFZ3JqbjU4cWs5SDQySHJFT3hpUHYyXzZidG5BeFpmZ3ltcjdmMU1DZThMczRVc3Z4TjI3TTJkVDRrRDJKZ1JmOEdjMmFzdVdTdEp3?oc=5","date":"2023-12-11","type":"pipeline","source":"Fierce Pharma","summary":"Sanofi taps local drugmaker Minapharm to crank out popular blood thinner Clexane in Egypt - Fierce Pharma","headline":"Sanofi taps local drugmaker Minapharm to crank out popular blood thinner Clexane in Egypt","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"marketed":10},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}